Healthy
Conditions
Brief summary
The aim of this study is to investigate the anti-exercise-fatigue effects of okara protein hydrolysate (OPH) in men
Detailed description
Each subject must undergo a cardiopulmonary capacity test to assess the maximum oxygen uptake 1 week before the intervention (day 1), and then eat the test food for 4 weeks (day 8 to day 35). Before and after the intervention (the 8th and 35th day), posture measurement, diet questionnaire survey and endurance exercise ability test were carried out. The trial period was 35 days. The subjects will take blood samples before, during, after, and 30 minutes and 60 minutes after the end of the two endurance exercise tests. During the whole period of participating in the program, blood will be collected 10 times, each with a blood volume of 15 mL. Gas is collected during the period and within 1 hour after exercise. Gas is collected every 15 minutes and 1 minute at a time. Analyze his exercise time, oxygen intake and blood biochemical value.
Interventions
DIETARY_SUPPLEMENTOkara protein hydrolysate (OPH)
Okara protein hydrolysate (OPH) was a pack of dried beige powder. It can be stored at room temperature, but it must be exposed to direct sunlight.
Sponsors
National Taichung University of Education
Chung Shan Medical University
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE
Eligibility
Sex/Gender
MALE
Age
20 Years to 40 Years
Healthy volunteers
Yes
Inclusion criteria
* The subject is a male and aged 20-40. * The subject has a usual exercise habit (exercising 2 times or more per week) and did not participate in professional sports competitions or professional sports training during the study period. * No smoking or drinking habits. * No food allergies and the liver function is normal. * No cardiovascular diseases or other chronic diseases, and no serious illnesses requiring hospitalization during the study period. * The subject can understand the test process described in the consent form and the possible potential risks and benefits, and can sign the consent form. * The subject can accept dietary control during the trial period.
Exclusion criteria
* Those who have taken nutritional supplements containing branched-chain amino acids. * Those who cannot complete the endurance exercise ability test. * Those who are diagnosed with kidney disease, heart disease, or cancer and are still under active treatment. * Have used other drugs, whose pharmacological effects may affect fatigue. * Subjects who have systemic infections and require systemic antibiotics.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change the metabolic substances level after intervention | 8th day, 35th day | Compare the difference of blood lactate, lactate dehydrogenase, and creatine kinase level after exercise between pre- and post-intervention |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change the exercise time after intervention | 8th day, 35th day | Compare the exercise time between pre- and post-intervention |
Countries
Taiwan
Outcome results
None listed